Search
for
Sort by
Research 31–60 of 1000+
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Dissecting the boundary of quiescence and activation of murine melanocyte stem cells in the hair follicle niche
- Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Reflectance confocal microscopy assessment of alopecia: A case report
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Skin aging: mechanisms, evaluation, and rejuvenation
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Hyperadrenocorticism in Ferrets
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Resident Memory T Cells in Autoimmune Skin Diseases
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Immune therapies for alopecia areata: evidence and new perspectives
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Targeting integrin pathways: mechanisms and advances in therapy
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer